Skip to main content
Figure 2 | Breast Cancer Research

Figure 2

From: Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort

Figure 2

Serum microRNA (miRNA) expression is associated with tumor subtype. (A) Serum miRNAs significantly associated with HER-2 expression (negative differences correspond to lower levels in women developing tumors with overexpression) (P ≤0.05). (B) Serum miRNAs significantly associated with nodal status (pN1 or higher versus pN0) (P ≤0.05). P values and percentage change were determined by using a linear mixed model.

Back to article page